The problem of cognitive bias is as pernicious as it is profound. We are all walking around with obscenely incomplete ‘data sets’ in our heads, which is why we need to keep talking to each other. A sound understanding of the fundamentals of cognitive biases will help protect against the development of dogmatic thinking within psychedelic science.
Read MoreThe Brazilian President Jair Bolsonaro has been pilloried for his cavalier attitude to Amazonian deforestation. This approach is, however, just a bough in a more troubling tree of disregard for the academy. Important lines of psychedelic research are similarly being squeezed to the brink of extinction - will they survive Bolsonaros’ big squeeze?
Read MoreAs current paradigms of archaic drug scheduling start to buckle under the weight of mounting empirical evidence, a zeitgeist of how scientific research is phased and how psychedelics might be re-classified is in order. This blogpost (also available as an audio ‘blogcast’) focusses on the current status of MDMA, but it seeks to ask a set of more broadly applicable questions to the road map to mainstream psychedelic legitimacy;
Where are we now? How did We get here? and - perhaps most importantly - where are we going…?
Read MoreCannabis has been hailed as a panacea, and as it breaks through the cracks and into mainstream society, we try to sort the bud from the chaff when it comes to its empirical potential to help improve both quality and longevity of life.
Read MoreWe are all shuffling towards death. Could psychedelics help it to be a bit less Parkinsonian and be a bit more Charleston?
Read More
